Tricuspid regurgitation laboratory findings
Jump to navigation
Jump to search
|
Tricuspid Regurgitation Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tricuspid regurgitation laboratory findings On the Web |
|
American Roentgen Ray Society Images of Tricuspid regurgitation laboratory findings |
|
Risk calculators and risk factors for Tricuspid regurgitation laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2] Basir Gill, M.B.B.S, M.D.[3]
Overview
There are no diagnostic laboratory findings associated with tricuspid regurgitation.
Laboratory Findings
- There are no diagnostic laboratory findings associated with tricuspid regurgitation. However, pre-intervention staging of renal and liver dysfunction is essential, as advanced TR frequently leads to cardiorenal and cardio hepatic syndromes. Laboratory monitoring should focus on markers of end-organ damage which, if caught early, may be reversible following successful tricuspid valve intervention.[1]
- Biomarkers can predict the cardiovascular complications in pregnancy and the following can be used to elevate:[2][3]
- N-terminal pro-B-type natriuretic peptide
- B-type natriuretic peptide
References
- ↑ Praz, F., Borger, M. A., Lanz, J., Marin-Cuartas, M., Abreu, A., Adamo, M., Ajmone Marsan, N., Barili, F., Bonaros, N., Cosyns, B., De Paulis, R., Gamra, H., Jahangiri, M., Jeppsson, A., Klautz, R. J. M., Mores, B., Pérez-David, E., Pöss, J., Prendergast, B. D., … Moorjani, N. (2025). 2025 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, 46(44), 4635–4736. https://doi.org/10.1093/eurheartj/ehaf194
- ↑ Tanous D, Siu SC, Mason J, Greutmann M, Wald RM, Parker JD; et al. (2010). "B-type natriuretic peptide in pregnant women with heart disease". J Am Coll Cardiol. 56 (15): 1247–53. doi:10.1016/j.jacc.2010.02.076. PMID 20883932.
- ↑ Kampman MA, Balci A, van Veldhuisen DJ, van Dijk AP, Roos-Hesselink JW, Sollie-Szarynska KM; et al. (2014). "N-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart disease". Eur Heart J. 35 (11): 708–15. doi:10.1093/eurheartj/eht526. PMID 24334717.